Mobile UPI  |   About UPI  |   UPI en Español  |   UPI Arabic  |   UPIU  |   My Account
Search:
Go

FDA approves fibromyalgia drug

|
|
 
  
Published: June 22, 2007 at 1:54 PM
Advertisement

WASHINGTON, June 22 (UPI) -- The U.S. Food and Drug Administration has approved pregabalin as the first drug to treat fibromyalgia.

The FDA said the drug, which is manufactured by Pfizer Inc. under the name Lyrica, reduces pain and improves daily functions for some patients with fibromyalgia.

Fibromyalgia is typically characterized by chronic pain, muscle stiffness and tenderness.

The disorder, which affects about 3 million to 6 million people in the United States each year, mostly affects women in early-to-middle adulthood.

Studies have shown that patients have decreased pain after taking Lyrica but the mechanism by which Lyrica produces such an effect is unknown, the FDA said in a release.

Lyrica already is approved for treating partial seizures, pain following the rash of shingles and pain associated with diabetes nerve damage, the FDA said.

© 2007 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.

Order reprints
  
Join the conversation
Most Popular Collections
The making of the Oscars The Chicago Auto Show 2011: The year in space
Mercedes-Benz fashion week In New York Tu Bishvat Migron settlement The Tibetan Moniam Festival in China
Additional Science News Stories
1 of 20
Syrian protests continue
View Caption
fark
Survey finds that men are quick to fall in love, roll over and fall asleep
World Fark Party II - Las Vegas Nevada: March 30 - Apr 1
Nerdiest sport ever: Combat juggling
Photoshop this topless athlete
Man rejects girlfriend's noodles, says toodles by leaving her in poodle of blood. Oodles of boodle...
Mormons tried to posthumously baptize Nobel laureate and Holocaust survivor Elie Wiesel but were...